• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A bisubstrate analog inhibitor for alpha(1----2)-fucosyltransferase.

作者信息

Palcic M M, Heerze L D, Srivastava O P, Hindsgaul O

机构信息

Department of Food Science, University of Alberta, Edmonton, Canada.

出版信息

J Biol Chem. 1989 Oct 15;264(29):17174-81.

PMID:2551897
Abstract

Porcine submaxillary beta-galactoside alpha(1----2)-fucosyltransferase is known to transfer a fucosyl residue from guanosine 5'-diphosphofucose (GDP-fucose) to the 2-OH group of beta-D-galactopyranosides with inversion of configuration at the fucopyranosyl anomeric carbon. A bisubstrate analog (1) of the postulated transition-state for this reaction, which has O-2 of phenyl beta-D-galactopyranoside attached to the terminal phosphorous of GDP through a flexible ethylene bridge, has been chemically synthesized and evaluated as an inhibitor of this enzyme. Compound 1 was found to be a competitive inhibitor with respect to both GDP-fucose and phenyl beta-D-galactopyranoside for both the membrane-bound and soluble forms of the fucosyltransferase. It was also a competitive inhibitor with respect to the alternate acceptor beta DGal(1----3)beta DGlcNAcO(CH2)8-COOMe. The Ki values were in the range 2.3-16 microM. Compound 1 is the first example of a bisubstrate analog inhibitor for a glycosyltransferase which binds to both the acceptor and donor recognition sites of the enzyme. The potential of a bisubstrate analog strategy for the production of specific glycosyltransferase inhibitors is discussed.

摘要

相似文献

1
A bisubstrate analog inhibitor for alpha(1----2)-fucosyltransferase.
J Biol Chem. 1989 Oct 15;264(29):17174-81.
2
Glycosyltransferases of the human cervical epithelium. I. Characterization of a beta-galactoside alpha-2-L-fucosyltransferase and the identification of a beta-N-acetylglucosaminide alpha-3-L-fucosyltransferase.
Biochim Biophys Acta. 1981 Jul 24;660(1):128-35. doi: 10.1016/0005-2744(81)90117-0.
3
Photoaffinity labeling of GDP-fucose:nLcOse4Cer alpha 1----3-fucosyltransferase from human small cell lung carcinoma NCI-H69 cells with the GDP-fucose analog GDP-hexanolaminyl-4-azidosalicylic acid.
J Biol Chem. 1990 Aug 5;265(22):13150-6.
4
Effects of endogenous soluble beta-galactoside binding lectins and protein inhibitor of fucosyltransferase on the enzymes involved in the intestinal fucosylation process.
Biochem Biophys Res Commun. 1992 Jun 15;185(2):617-23. doi: 10.1016/0006-291x(92)91669-h.
5
A sequence motif involved in the donor substrate binding by alpha1,6-fucosyltransferase: the role of the conserved arginine residues.一种参与α1,6-岩藻糖基转移酶与供体底物结合的序列基序:保守精氨酸残基的作用。
Glycobiology. 2000 May;10(5):503-10. doi: 10.1093/glycob/10.5.503.
6
Mechanism and specificity of human alpha-1,3-fucosyltransferase V.人α-1,3-岩藻糖基转移酶V的作用机制与特异性
Biochemistry. 1996 Aug 27;35(34):11183-95. doi: 10.1021/bi961065a.
7
Modified procedure for detection of GDP-L-fucose:galactoside 2'-fucosyltransferase.检测GDP-L-岩藻糖:半乳糖苷2'-岩藻糖基转移酶的改良方法。
Clin Chim Acta. 1980 Nov 20;108(1):41-8. doi: 10.1016/0009-8981(80)90290-9.
8
Inhibition kinetics of carba- and C-fucosyl analogues of GDP-fucose against fucosyltransferase V: implication for the reaction mechanism.GDP-岩藻糖的碳环和C-岩藻糖基类似物对岩藻糖基转移酶V的抑制动力学:对反应机制的启示
Bioorg Med Chem Lett. 2004 Feb 9;14(3):571-3. doi: 10.1016/j.bmcl.2003.12.003.
9
Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.潜在α1,3-岩藻糖基转移酶抑制剂的合成与分析
Bioorg Med Chem. 2014 Nov 15;22(22):6430-7. doi: 10.1016/j.bmc.2014.09.038. Epub 2014 Oct 2.
10
Mechanism of human alpha-1,3-fucosyltransferase V: glycosidic cleavage occurs prior to nucleophilic attack.人α-1,3-岩藻糖基转移酶V的作用机制:糖苷键断裂发生在亲核攻击之前。
Biochemistry. 1997 Jan 28;36(4):823-31. doi: 10.1021/bi962284z.

引用本文的文献

1
2,2-Difluoro Derivatives of Fucose Can Inhibit Cell Surface Fucosylation without Causing Slow Transfer to Acceptors.岩藻糖的2,2-二氟衍生物可抑制细胞表面岩藻糖基化,而不会导致向受体的缓慢转移。
JACS Au. 2024 Sep 23;4(10):3953-3963. doi: 10.1021/jacsau.4c00681. eCollection 2024 Oct 28.
2
Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.生物合成机制参与异常糖基化:开发抗癌药物的有前途的靶点。
Front Oncol. 2015 Jun 25;5:138. doi: 10.3389/fonc.2015.00138. eCollection 2015.
3
Chemical tools to explore nutrient-driven O-GlcNAc cycling.
用于探索营养物质驱动的O-连接N-乙酰葡糖胺循环的化学工具。
Crit Rev Biochem Mol Biol. 2014 Jul-Aug;49(4):327-42. doi: 10.3109/10409238.2014.931338.
4
Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors.双底物 UDP-肽缀合物作为人 O-GlcNAc 转移酶抑制剂。
Biochem J. 2014 Feb 1;457(3):497-502. doi: 10.1042/BJ20131272.
5
NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments.基于 NMR 的人血 B 型半乳糖基转移酶受体结合部位与分子片段的研究
Glycoconj J. 2010 Apr;27(3):349-58. doi: 10.1007/s10719-010-9282-5. Epub 2010 Mar 9.
6
Synthesis of the acceptor analog alphaFuc(1-->2)alphaGal-O(CH2)7 CH3: a probe for the kinetic mechanism of recombinant human blood group B glycosyltransferase.
Glycoconj J. 1999 Oct;16(10):599-606. doi: 10.1023/a:1007072832421.
7
Intervention of carbohydrate recognition by proteins and nucleic acids.蛋白质和核酸对碳水化合物识别的干预。
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12086-93. doi: 10.1073/pnas.93.22.12086.